Company Profile for Kubota Vision Inc. (dba of Acucela Inc.)

April 1, 2020 Off By BusinessWire

–(BUSINESS WIRE)–Kubota Vision Inc. is a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596) committed to translating innovation into a diverse portfolio of drugs and devices to preserve and restore vision for millions of people worldwide. Kubota Vision’s development pipeline include drug candidates for the treatment of diabetic retinopathy, Stargardt disease, and optogenetics-based gene therapy for the treatment of retinitis pigmentosa. The company is also developing a handheld OCT device for the monitoring of neovascular retinal diseases, to be used directly by patients.

Company:

Kubota Vision Inc. (dba of Acucela Inc.)

 

 

Headquarters Address:

818 Stewart Street, Suite 1110

 

Seattle, WA 98101

 

 

Main Telephone:

+1.206.805.8300

 

 

Website:

https://www.kubotavision.com/

 

 

Type of Organization:

Private

 

 

Industry:

Biotechnology, Medical Devices, Pharmaceutical

 

 

Key Executives:

CEO: Ryo Kubota

 

 

Investor Relations

 

Contact:

Hiroki Maekawa

Phone:

+81.3.6550.8928

Email:

[email protected]

 

 

Public Relations

 

Contact:

Yumiko Hamanaka

Phone:

+1.206.805.8300

Email:

[email protected]

 

 

Business Development

 

Contact:

– –

Email:

[email protected]